Can a smart drug cross the Blood-Brain barrier to attack breast cancer metastases?
Disease control
Recruiting now
This phase 2 trial is testing whether the investigational drug datopotamab deruxtecan (Dato-DXd) can safely and effectively treat HER2-negative breast cancer that has spread to the brain. The study enrolls adults with metastatic breast cancer who have brain metastases that are ei…
Phase: PHASE2 • Sponsor: Nancy Lin, MD • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC